The alterations of serum FGF-21 levels, metabolic and body composition in early breast cancer patients receiving adjuvant endocrine therapy-Reference-Cited by-同舟云学术

The alterations of serum FGF-21 levels, metabolic and body composition in early breast cancer patients receiving adjuvant endocrine therapy

Published:2017-05-05 Issue:4 Volume:18 Page:441-449
ISSN:1574-0153
Container-title:Cancer Biomarkers
language:
Short-container-title:CBM

Author:

Akyol Murat¹,Alacacioglu Ahmet²,Demir Leyla³,Kucukzeybek Yuksel²,Yildiz Yasar²,Gumus Zehra²,Kara Mete²,Salman Tarik²,Varol Umut²,Taskaynatan Halil²,Oflazoglu Utku²,Bayoglu Vedat²,Tarhan Mustafa Oktay⁴

Affiliation:

1. Department of Medical Oncology, Manisa State Hospital, Manisa, Turkey

2. Department of Medical Oncology, Izmir Katip Celebi University Ataturk Training and Research Hospital, Izmir, Turkey

3. Department of Biochemistry, Izmir Katip Celebi University Ataturk Training and Research Hospital, Izmir, Turkey

4. Institute of Oncology, Dokuz Eylul University, Izmir, Turkey

Publisher

IOS Press

Subject

Cancer Research,Genetics,Oncology,General Medicine

Reference52 articles.

1. Cancer statistics;Siegel;CA Cancer J Clin,2014

2. Aromatase inhibitors: Rationale for use following antiestrogen therapy;Yue;SeminOncol,1999

3. Overview of the pharmacology of the aromatase inactivator exemestane;Bruggemeier;Breast Cancer Res Treat,2002

4. Long-term mortality of women with a diagnosis of breast cancer;Levi;Oncology,2002

5. Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer;Harvey;J Clin Oncol,1999

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-alcoholic fatty liver disease promotes breast cancer progression through upregulated hepatic fibroblast growth factor 21;Cell Death & Disease;2024-01-18

2. Lipid changes during endocrine therapy in early-stage breast cancer patients: A real-world study;Lipids in Health and Disease;2024-01-08

3. Non-alcoholic fatty liver disease promotes breast cancer progression through upregulated hepatic fibroblast growth factor 21;2023-05-03

4. Comparison of changes in lipid profiles of premenopausal women with early-stage breast cancer treated with different endocrine therapies;Scientific Reports;2022-12-31

5. Association of serum fibroblast growth factor 21 levels with skeletal muscle mass and mortality in chronic hemodialysis patients;Journal of the Formosan Medical Association;2022-12